Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Statistics

Total Valuation

BCAX has a market cap or net worth of $1.42 billion. The enterprise value is $886.15 million.

Market Cap	1.42B
Enterprise Value	886.15M

Important Dates

The last earnings date was Monday, May 11, 2026, before market open.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

BCAX has 65.70 million shares outstanding. The number of shares has increased by 85.90% in one year.

Current Share Class	65.70M
Shares Outstanding	65.70M
Shares Change (YoY)	+85.90%
Shares Change (QoQ)	+10.11%
Owned by Insiders (%)	1.93%
Owned by Institutions (%)	72.69%
Float	36.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.76
P/TBV Ratio	2.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.85, with a Debt / Equity ratio of 0.00.

Current Ratio	13.85
Quick Ratio	13.72
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.34% and return on invested capital (ROIC) is -22.32%.

Return on Equity (ROE)	-32.34%
Return on Assets (ROA)	-21.09%
Return on Invested Capital (ROIC)	-22.32%
Return on Capital Employed (ROCE)	-33.85%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.53M
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BCAX has paid $197,000 in taxes.

Income Tax	197,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+48.60%
50-Day Moving Average	21.20
200-Day Moving Average	16.99
Relative Strength Index (RSI)	51.76
Average Volume (20 Days)	495,533

Short Selling Information

The latest short interest is 8.90 million, so 13.54% of the outstanding shares have been sold short.

Short Interest	8.90M
Short Previous Month	9.33M
Short % of Shares Out	13.54%
Short % of Float	24.29%
Short Ratio (days to cover)	15.71

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-174.06M
Pretax Income	-157.12M
Net Income	-157.32M
EBITDA	-173.93M
EBIT	-174.06M
Earnings Per Share (EPS)	-$2.80

Balance Sheet

The company has $539.75 million in cash and $1.44 million in debt, with a net cash position of $538.31 million or $8.19 per share.

Cash & Cash Equivalents	539.75M
Total Debt	1.44M
Net Cash	538.31M
Net Cash Per Share	$8.19
Equity (Book Value)	513.96M
Book Value Per Share	7.84
Working Capital	505.58M

Cash Flow

In the last 12 months, operating cash flow was -$116.24 million and capital expenditures -$340,000, giving a free cash flow of -$116.58 million.

Operating Cash Flow	-116.24M
Capital Expenditures	-340,000
Depreciation & Amortization	130,000
Net Borrowing	n/a
Free Cash Flow	-116.58M
FCF Per Share	-$1.77

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-85.90%
Shareholder Yield	-85.90%
Earnings Yield	-11.04%
FCF Yield	-8.18%

Analyst Forecast

The average price target for BCAX is $31.46, which is 45.11% higher than the current price. The consensus rating is "Buy".

Price Target	$31.46
Price Target Difference	45.11%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1